Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2016

Jan 7, 2016

6990_dirs_2016-01-07_77cd65a2-bad7-498e-a80a-49d4aeb72785.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2016-01-05

Reporting Person: YANAY YAKY (Director, CFO, COO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-05 Common Stock A 150000 Acquired 1451616 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 41499 Indirect

Footnotes

F1: The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter.